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Background: An antibacterial is a substance that either kills bacteria or slows their growth. Antifungal are the
agents that use drugs for treatment of fungal infections. 5-Chloro-1,3-benzoxazol-2(3 H)-one (5-Chloro
Benzoxazolinone) contains an azole ring structure. Numbers of azole compounds are reported as antibacterial and
antifungal agents. Benzoxazolinones naturally occur in plants. They play a role as defense compounds against
bacteria, fungi, and insects.
Results: In this article, synthesis of six Benzoxazolinone derivatives with various substituents is presented.
Benzoxazolinone substituted with p-aminobenzoic acids and sulphanilamide derivatives. The above both
substituents are reported as potent antimicrobial agents. Attachment with azole leads to increase its
potency. The other substituents are 2,4-dichlorobezylchloride. The same rings are found in miconazole and
this may lead to increase its antifungal activity. Fluconazole also contains triazole moiety and triazole is
having other numbers of activity like antimicrobial, anti-inflammatory, local anesthetic, antiviral, anticancer,
antimalarial, etc. Here, there is a substitution for azole ring at 5-Chloro position which might increase
antibacterial and antifungal activity. The synthesis and interpretation of six final compounds and three
intermediates are presented in this article. Synthesis of 5-Chloro Benzoxazolinone derivatives substituted with
Halogenated rings, sulfonated and benzylated derivatives and azole derivatives. There is a synthesis of P2A,
P2B, P4A, P4B, P5A, and P6A compounds and their structures were characterized by UV–Visible, IR, MASS
spectroscopy, and NMR spectroscopy.
Conclusions: The antibacterial activity of all six compounds is measured against various Gram-positive and
Gram-negative bacteria and against fungi. Compounds P4A and P4B have good antibacterial and antifungal
activity, half of the Ampicillin and Cephalexin. P4A, P4B, P6A have good activity against Staphylococcus
aureus and Escherichia coli. Compound P2B has good antifungal activity, half of the Miconazole against
Candida albicans. P2A, P2B, P5A, P6A have almost equal antibacterial activity.
Keywords: Antibacterial, Antifungal, Benzoxazolinone, p-aminobenzoic acid, Sulfanilamide, TriazoleBackground
An antibacterial is a substance that either kills bacteria
or slows their growth. An antifungal drug is a medica-
tion used to treat fungal infection such as athlete’s foot,
ring worm, candidiasis (thrust), serious systemic infec-
tions such as cryptococcal meningitis and other. The
benzoxazolinone ring is having number of activities.* Correspondence: modiyapriya@gmail.com
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provided the original work is properly cited.Benzoxazolinone derivatives naturally occur in plants. It
has natural defense mechanism in plants against bac-
teria, fungi, and insects. Antibiotics Qustinamycin and
N-acetyl Quistinamycin belong to this group. As described
in literature review, it has potential as antibacterial and
antifungal agents. A number of azoles are used in fungi
and bacterial infection. So, here we are going to
synthesize various derivatives of benzoxazolinone with
various substituents.en Access article distributed under the terms of the Creative Commons Attribution






Where Az= Triazole,  Imidazole, benzimidazole 
Compound code X1 X2 X3
3a F H F 
3b Cl H Cl
3c H Cl Cl
3d Cl H H 
7a F H F 
7b Cl H Cl
7c H Cl Cl
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5-Chloro-2(3 H)-benzoxazolinone-3-acetyl-2-(p-substituted
benzalhydrazone) and 5-chloro-2(3 H)-benzoxazolinone-3-
acetyl-2-(p-substituted acetophenone) hydrazone deriva-
tives were synthesized (Figure 1). Among them, the analytical
data of five original compounds were given. In this
study, the microwave synthesis method and antimicro-
bial evaluation of all the compounds were also reported
for the first time. The minimum inhibition concentration
(MIC) values of the compounds were determined by the
Microdilution method using two Gram-positive bacteria
(Staphylococcus aureus, Bacillus subtilis), two Gram-negative
bacteria (Pseudomonas aeruginosa, Escherichia coli), and two
yeast-like fungi (Candida albicans, Candida parapsilosis) [1].
Fang et al. [2] have reported N-(2-(1 H-1,2,4-triazol-1-yl)
ethyl)-N-(2,4-difluorobenzyl)-2-(1 H-1,2,4-triazol-1-yl)etha-




chloride and number of other compounds having potent
antibacterial and antifungal activity (Figure 2). Miconazole
contains two 2,4-dichlorobenzyl ring and imidazole as
azole. As per the SAR study of the above compounds, the
halogenated ring is responsible for the antifungal activity
potential and azoles are also present. So, we will attach the
halogenated ring to benzoxazolinone and synthesize the
P2A and P2B compounds. A series of novel benzoxazole
benzenesulfonamides was synthesized (Figure 3) as inhibi-
tors of fructose-1,6-bisphosphatase (FBPase-1), and they
are proved as antibacterial agents [3]. The sulfanilamide
derivatives and p-aminobenzoic acid are very goodFigure 1 5-Chloro-2(3 H)-benzoxazolinone-3-acetyl-2-
(p-substituted benzalhydrazone and 5-chloro-2(3 H)-
benzoxazolinone-3-acetyl-2-(p-substituted acetophenone)
hydrazone derivatives.
Figure 2 N-(2-(1 H-1,2,4-triazol-1-yl)ethyl)-N-(2,4-difluorobenzyl)-
2-(1 H-1,2,4-triazol-1-yl)ethanamine hydrochloride, N-(2-(1 H-
1,2,4-triazol-1-yl)ethyl)-N-(2,4-dichlorobenzyl)-2-(1 H-1,2,4-
triazol-1-yl)ethanamine hydrochloride, N-(2-(1 H-1,2,4-triazol-1-
yl)ethyl)-N-(3,4-dichlorobenzyl)-2-(1 H-1,2,4-triazol-1-yl)
ethanamine hydrochloride.
Figure 3 Benzoxazole benzenesulfonamide derivatives.
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here we will attach the sulfanilamide and p-aminobenzoic
acid with benzoxazolinone. Triazole derivatives are having
number of activities. Moreover, fluconazole is having two
triazole ring and 2,4-difluorobenzyl ring. Wang et al. [4]
have reported triazole substituted with sulfanilamide as







The microbiological assay is based upon a comparison
of inhibition of growth of micro-organisms by measured
concentrations of test compounds with that produced by
known concentration of a standard antibiotic. Two
methods generally employed are turbidometric (tube-
dilution) method and cylinder plate (cup-plate) method.
In the turbidometric method, inhibition of growth of
microbial culture in a uniform solution of antibiotic in
a fluid medium is measured. It is compared with the
synthesized compounds. Here, the presence or absence
of growth is measured. The cylinder plate method
depends upon diffusion of antibiotic from a vertical cy-
linder through a solidified agar layer in a Petridish or
plate to an extent such that growth of added micro-
organisms is prevented entirely in a zone around the
cylinder containing solution of the antibiotics. The
cup-plate method is simple and measurement of inhib-
ition of microorganisms is also easy. Here, we have
use this method for antibacterial screening of the testFigure 4 4-Amino-N-((1-pentyl-1 H-1,2,3-triazol-4-yl)methyl)
benzenesulfonamide, 4-amino-N-((1-hexyl-1 H-1,2,3-triazol-4-yl)
methyl)benzenesulfonamide.compounds. The media was prepared from nutrient
agar 2%, peptone 1%, beef extract 1%, sodium chloride
0.5%, and distilled water up to 100 mL. All the ingre-
dients were weighed and added to water. This solution
was heated on water bath for about one and half-hour
till it became clear. This nutrient media was sterilized
by autoclave. The antibacterial and antifungal activity
was measured against Bacillus subtillis (MTCC-212),
Staphylococcus aureus (MTCC-737) were used as
Gram-positive bacteria, Escherichia coli (NCLM-2066)
were used as Gram-negative bacteria and Candida
albicans (MTCC-227) was used as fungi for this study.
The master culture was prepared on agar slant of the
above nutrient media and kept in refrigerator. The
working culture was prepared from it by weekly trans-
ferred in nutrient agar medium [5,6].
Preparation of inoculums
In the aseptic condition from the working culture, small
amount of culture was transferred to about 10–15 mL of
sterile normal saline (0.9% NaCl solution). This solution
was gently mixed and used for the antibacterial activity.
About 0.5 mL of inoculum was added to the sterilized
Petridish and melted agar cooled to 45°C was added,
mixed gently, and allowed to solidify. Then, Watmann
filter paper disk was kept in each plate which was soaked
in test drug solutions. The solution was allowed to dif-
fuse for a period of 90 min. The Petri dishes were then
incubated at 37°C for 24 h after which zone of inhibition
was measured.
Preparation of test solution
Specified quantity of the compound was weighed and
dissolved in 5 mL of DMSO and further dilution was
made to get the concentration of 500, 1000, and
1500 μg/mL. Similarly, the standard drugs Ampicillin,
Cephalexin, and Miconazole were dissolved in appro-
priate quantity of water to obtain the concentration
of 500, 1000, and 1500 μg/mL each. The images of
zone of inhibition are given in Figures 5, 6, 7, and 8,
and the results are shown in Table 1, and the histo-
gram of antibacterial and antifungal activity is given
in Figure 9.
MIC
MIC is the lowest concentration of an antimicrobial
that will inhibit the visible growth of a microorganism
after overnight incubation. MIC values can be deter-
mined by a number of standard test procedures. The
most commonly employed methods are the tube dilution
and agar dilution methods. Serial dilutions are made of
the products in bacterial growth media. The test organ-
isms are then added to the dilutions of the products, incu-
































































































Figure 5 Zone of inhibition of Ampicillin in B. subtilis.
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tions are important in diagnostic laboratories to confirm
resistance of microorganisms to an antimicrobial agent
and also to monitor the activity of new antimicrobial
agents. A MIC is generally regarded as the most basic
laboratory measurement of the activity of an antimicro-
bial agent against an organism. The data derived from
the test can be corrected with the knowledge of
expected or measured compound level in vivo to predict
the efficacy of compound. In this study, MIC was deter-
mined using “Serial tube dilution technique”. In this
technique, the tubes of broth medium, containing
graded doses of compounds, are inoculated with the test
organisms. After suitable incubation, growth will occurin those tubes where the concentration of compound is
below the inhibitory level and the culture will become
turbid (cloudy). Therefore, growth will not occur above
the inhibitory level and the tube will remain clear.
Results are shown in Table 2 [7].
Procedure
 Twelve test tubes were taken, nine of which were
marked 1, 2, 3, 4, 5, 6, 7, 8, 9, and the rest three
were assigned as TM (medium), TMC (medium +
compound), and TMI (medium + inoculum).
 2 mL of nutrient broth medium was poured to each
of the 12 test tubes.
Figure 6 Zone of inhibition of Cephalexin in E. coli.
Figure 8 Zone of inhibition of P2B in C. albicans.
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in an autoclave for 15 lbs/sq. inch pressure.
 After cool 2 mL of the sample solution (5 mg/mL)
was added to the first test tube and mixed well and
then 2 mL of this content was transferred to the
second test tube.
 The content of the second test tube was mixed well
and again 2 mL of this mixture was transferred to
the third test tube. This process of serial dilution
was continued up to the ninth test tube.Figure 7 Zone of inhibition of P4B in S. ureu. l of properly diluted inoculum was added to each of
nine test tubes and mixed well.
 To the control test tube TMC, 2 mL of the sample
was added, mixed well and 2 mL of this mixed
content was discarded to check the clarity of the
medium in presence of diluted solution of the
compound.
 10 μL of the inoculum was added to the control test
tube TMI, observed the growth of the organism in
the medium used.
 The control test tube TM, containing medium only
was used to confirm the sterility of the medium.
 All the test tubes were incubated at 37°C for 18 h.
 The resultant concentration in all the nine test tubes
will be 2.5 mg/mL, 1.25 mg/mL, 625, 312.5, 156.25,
78.1, 39.06, 19.53, 9.76 μg/mL.Experimental
All the chemicals used for the synthesis of title com-
pounds were procured from Himedia Laboratories
Pvt. Ltd., Mumbai, S. D. Fine Chem. Ltd., Mumbai,
Finar Chemicals Ltd., Ahmedabad, Loba chemie Pvt.
Ltd., Mumbai, Chemdyes Corporation, Ahmedabad,
Spectrochem Pvt. Ltd., Mumbai. The scheme of syn-
thesis is given in Scheme 1. The chemicals were used
without further purification. All the melting points
were determined in open capillaries and are uncor-
rected. Thin layer chromatography was performed on
microscopic slides (2 × 7.5 cm2) coated with silica-
Gel-G and spots were visualized under UV light. UV
spectra were recorded in U.V-1700 Shimadzu spec-
trophotometer. IR spectra of all the compounds were
recorded in KBr on FT-IR 8400 S Shimadzu
Figure 9 Histogram of antibacterial/antifungal act.






Zone of inhibition (mm)
B. subtilis S. aureus E. coli C. albicans
P2A 0.5 2 1 - 2
1.0 4 3 2 4
1.5 6 5 4 7
P2B 0.5 – – – –
1.0 1 2 3 3
1.5 3 3 5 6
P4A 0.5 – 5 – –
1.0 6 7 2 3
1.5 7 8 3 5
P4B 0.5 – 3 1 3
1.0 4 5 3 4
1.5 7 6 4 7
P5A 0.5 1 – – 2
1.0 5 3 – 5
1.5 6 5 3 7
P6A 0.5 4 3 – –
1.0 6 5 2 4
1.5 7 7 5 6
Ampicillin 0.5 10 11 8 –
1.0 12 12 10 –
1.5 14 14 12 –
Cephalexin 0.5 7 7 5 –
1.0 9 8 8 –
1.5 11 10 9 –
Miconazole 0.5 – – – 6
1.0 – – – 7
1.5 – – – 9




B. subtilis S. aureus E. coli C. albicans
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http://www.orgmedchemlett.com/content/2/1/29spectrophotometer using KBr. Mass spectra were
obtained using 2010EV LCMS Shimadzu instrument.
The 1 H NMR was recorded on Bruker advanced–II
NMR-400 MHz instruments using CDCl3/DMSO-d6
as solvent and tetramethylsilane as internal standard,
chemical shifts were expressed as δvalues (ppm).P2A >312 >312 >312 >312
P2B >312 >312 >312 >156
P4A >156 >156 >156 >156
P4B >156 >156 >156 >156
P5A >312 >312 >312 >156
P6A >312 >156 >312 >312
Ampicillin >39 >78.1 >1250 –
Cephalexin >39 >78.1 >78.1 –
Miconazole – – – >78.1Preparation of 5-chloro-1,3-benzoxazol-2(3H)-one (P1A)
(7.15 g, 0.05 mol) 2-amino-4 chlorophenol was dissolved
in 10 mL of Dimethyl formamide. (3 g, 0.05 mol) of urea
was added in this mixture. The whole mixture was reflux
for 3 h at 60°C till all the ammonia gas is liberated.
Then, pour this mixture in ice-cold water with constant
stirring and collect the precipitates. The product was
recrystallized from Rectified ethanol. The compound
was characterized by TLC, UV, IR, and melting pointdetermination (Tables 3 and 4). Mobile phase of TLC
was hexane:ethylacetate (3:2) [1] Scheme 2.Preparation of 3-benzyl-5-chloro-1,3-benzoxazol-2
(3H)-one (P2A)
(1.69 g, 0.010 mol) of P1A was added in 5 mL of aceto-
nitrile in a round bottom flask. To this mixture, (1.26 g,
0.01 mol) of benzyl chloride (density 1.100 g/cm3) was
added. The whole solution was reflux for 3 h at 60°C.
Then, this solution was added in cold water with
constant stirring. Product was collected and recrystal-
lized from rectified ethanol. The compounds were char-
acterized by TLC, UV, IR, MASS, and melting point
determination (Tables 3 and 4). Mobile phase of TLC











Scheme 1 Synthesis of 5-chloro-1,3-benzoxazol-2(3 H)-one (P1A).
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3-benzoxazol-2(3 H)-one (P2B)
(1.69 g, 0.01 mol) of P1A was added to the 5 ml of
acetonitrile in a round bottom flask. To this mixture,
(1.365 g, 0.01 mol) of 2,4-dichlorobenzyl chloride
(density 1.386 g/cm3) was added. The whole mixture
was refluxed for 4 h at 60°C and reaction was moni-
tored by TLC. Then, resultant mixture was added in
cold water with constant stirring. The product was
collected and recrystallized from rectified ethanol.
The compound was characterized by TLC, UV, IR,
MASS, NMR, and melting point determination
(Tables 3 and 4). Mobile phase of TLC was hexane:
ethyl acetate (3:2) [2].Preparation of 5-azido-3-benzyl-1,3-benzoxazol-2(3H)-one
(P3A)
(2.59 g, 0.01 mol) of P2A was dissolved in 5 mL of di-
methyl formamide in a conical flask. (0.21 g, 0.01 mol)
of sodium azide and 0.5 g of zinc chloride were added.
Then, 5 mL of carbon disulfide was added and mixed
well. The mixture was kept at room temperature for
10–12 h. Then, the mixture was added in ice-cold
water. The azide product was collected and used for
further reaction. The compound was characterized by
TLC, UV, IR, and melting point determination (Tables 3
and 4). Mobile phase of TLC was hexane:ethyl acetate













P1A C7H4ClNO2 169.565 158 70.1 0.73
P2A C14H10ClNO2 259.68 169 78.4 0.84
P2B C14H8Cl3NO2 328.577 176 56.9 0.68
P3A C14H10N4O2 266.25 176 70.17 0.78
P3B C7H4N4O2 176.13 168–172 94.23 0.74
P4A C16H12N4O2 292.29 135 37.03 0.87
P4B C9H6N4O2 202.169 179–183 42.15 0.54
P5A C20H17N3O4S 395.43 195–200 65.79 0.71
P6A C21H16N2O4 360.36 182 54.02 0.72Preparation of 5-azido-1,3-benzoxazol-2(3H)-one (P3B)
(1.69 g, 0.01 mol) of P1A was dissolved in 5 mL of di-
methyl formamide in a conical flask. (0.21 g, 0.01 mol)
of sodium azide and 0.5 g of zinc chloride were added
in the above solution. Then, 5 mL of carbon disulfide
was added and kept the mixture at room temperature
for 10–12 h. Then, the mixture was added in ice-cold
water. The azide product was collected and used for
further reaction. The compound was characterized by
TLC, UV, IR, and melting point determination (Tables 3




(2.66 g, 0.01 mol) of P3A was dissolved in 10 mL of abso-
lute ethanol and it was refluxed with (0.86 g, 0.01 mol) of
vinyl acetate (density 0.93 g/cm3) for 8 h. The reaction was
monitored by TLC. Mobile phase was hexane:ethyl acetate
(2:1). Then, the product was collected from ice-cold water
and recrystallized from rectified ethanol. The compound
was characterized by TLC, UV, IR, MASS, NMR, and melt-
ing point determination [8].
Preparation of 5-(1H-1,2,3-triazol-1-yl)-1,3-benzoxazol-2
(3H)-one (P4B)
(1.76 g, 0.01 mol) of P3B was dissolved in 10 mL of
absolute ethanol and it was refluxed with (0.86 g,
0.01 mol) of vinyl acetate (density 0.93 g/cm3) for
6 h. The reaction was monitored by TLC. Mobile
phase was hexane:ethyl acetate (3.5:1.5). Then, the
product was collected from ice-cold water and
recrystallized from rectified ethanol. The compound
was characterized by TLC, UV, IR, MASS, NMR, and
melting point determination [8].
Preparation of 4-amino-N-(3-benzyl-2-oxo-2,3-dihydro-1,
3-benzoxazol-5-yl)benzenesulfonamide (P5A)
(2.59 g, 0.010 mol) of P2A was dissolved in 10 mL
of absolute ethanol. Equal weight of potassium car-
bonate (anhydrous) and (1.72 g, 0.010 mol) of sulf-
anilamide was added and the whole mixture was
refluxed for 3 h and the reaction was monitored by
TLC. Mobile phase was hexane:ethyl acetate (3.5:1.5).
Then, add the mixture in water and reprecipitate the
Table 4 Spectral data of compounds
Compound code UV λ-max (cm) IR KBr (cm-1) Mass m/z (abundance) H1 NMR (CDCl3) signals, δ,
multiplicity, J value (Hz)
P1A 283.0 3055.03 (−NH–CO–), – –
800–400(Ar–Cl),
1481.23(Cyclic Ester),
1600–1400 (C = C)
1782.10 (C = O)
P2A 282.0 3051.18 (=N–CO–), 259(M–), 7.1 (s, 5H, Ar–H),
800–400(Ar–Cl), 168(91), 4.2 (s, 2H, –CH2–),
1481.23(Cyclic Ester), 223(35), 7.1, 7.0 (m, 2 H, –3CH–
1600–1400 (C = C) 186(73), 4CH–),
713.0 & 694.33 (Mono Substituted
benzene ring)
113(164) 7.3, 7.2 (m, 1 H, –6CH)
1774.39 (C = O)






1600–1450 (C = C), 218(105),
3050–3010 (−C–H str.), 181(146),
1778.25 (C = O) 159(167)
P3A 282.0 3039.09 (=N–CO–), – –
713.1 & 698.18 (Mono substituted
benzene ring),
1481.23(Cyclic Ester),
1600–1400 (C = C),
3050–3010 (−C–H str),
1782.10 (C = O)
P3B 282.0 3055.03 (−NH–CO–), – –
1485.09(Cyclic Ester),
1600–1450 (C = C),
3050–3010 (−C–H str),
1782.10 (C = O)
P4A 282.0 3058.89 (=N–CO–), 292(M–), 7.02 (s, 5 H, Ar–H),
1485.09(Cyclic Ester), 168(106), 4.02 (s, 2 H, –CH2–),
1600–1450 (C = C), 224(68), 7.8 (s, 1 H, 6CH),
713.61 & 690.47 (Mono substituted
benzene ring),
201(91), 7.36, 7.35 (m, 2 H, –3CH–4CH–),
3050–3010 (−C–H str), 133(159) 7.1, 7.0 (d, 2 H, –CH=CH– in triazole)
1762.82 (C = O)
P4B 282.0 3055.03 (−NH–CO–), 202(M–),
1481.23(Cyclic Ester), 168(34),
1600–1400 (C = C), 134(68)
3050–3010 (−C–H str),
1782.10 (C = O)
P5A 281.0 & 218.0 1261.36 & 1149.50 (−SO2NH–), 395(M
-), –
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Table 4 Spectral data of compounds (Continued)
3055.03 (=N–CO–), 167.9(227),
1620.09 (−NH2), 224(171)
1299.93 & 1149.50 (−S = O), 304(91)
1477.37(Cyclic Ester), 133(262)
1782.10 (C = O)
P6A 282.0 & 219.0 1782.10 (−COOH) 360(M–), 7.02 (s, 5 H, Ar–H),
3058.89 (=N–CO–), 310.8(49), 7.01,7.00 (d, 4 H, CH in PABA),
713.60 & 694.33 (Mono substituted
benzene ring),
168(192), 5.01 (s, 1 H, NH),
1481.23(Cyclic Ester), 223.9(136), 11.51 (s, 1 H, –COOH),
1600–1400 (C = C) 132(227) 4.3 (s, 2 H, –CH2–),
1616.24 (C = O) 7.24, 7.22 (m, 1 H, 6CH),
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http://www.orgmedchemlett.com/content/2/1/29product by acidifying with conc. HCl. Collect the
crude P5A and recrystalize byrectified ethanol. The
compound was characterized by TLC, UV, IR, MASS,
and melting point determination [4,8].
Preparation of 4-[(3-benzyl-2-oxo-2,3-dihydro-1,
3-benzoxazol-5-yl)amino]benzoic acid (P6A)
(2.59 g, 0.010 mol) of P2A was dissolved in 10 mL of
absolute ethanol. Equal weight of potassium carbonate
(anhydrous) and (1.37 g, 0.010 mol) of p-aminobenzoic
acid was added and the whole mixture was refluxed
for 3 h and the reaction was monitored by TLC. Mo-
bile phase was hexane:ethyl acetate (3.5:1.5). Then, add
the mixture in water and reprecipitate the product by
acidifying with conc. HCl. Collect the crude P6A and
recrystalize by rectified ethanol. The compound was





















Scheme 2 Synthesis of 3-benzyl-5-chloro-1,3-benzoxazol-2(3 H)-
one (P2A), 5-chloro-3-(2,4-dichlorobenzyl)-1,3-benzoxazol-2(3
H)-one (P2B), 5-azido-1,3-benzoxazol-2(3 H)-one (P3B).Conclusions
Benzoxazole was reported as naturally occurring plant
product and considered responsible for antibacterial ac-
tivity in plant protection. We have synthesized and con-
cluded its other synthetic derivatives. Compounds P4A
and P4B have good antibacterial and antifungal activity,
half of the Ampicillin and Cephalexin. P4A, P4B, P6A
have good activity against S. aureus and E. coli. Com-
pound P2B has good antifungal activity, half of the
Miconazole against C. albicans. P2A, P2B, P5A, P6A












































Scheme 4 Synthesis of 5-(1 H-1,2,3-triazol-1-yl)-1,3-benzoxazol-
2(3H)-one (P4B), 3-benzyl-5-(1H-1,2,3-triazol-1-yl)-1,
3-benzoxazol-2(3H)-one (P4A).
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